1 |
0.02% fm, sh, as |
- |
- |
- |
- |
053 [1] 53 💬 |
2 |
1500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
3 |
250mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
4 |
2l polyethylene glycol/ascorbic acid |
Ascorbic acid |
[2] D00018 D00018, D03370 D03370 💬 |
- |
- |
097 [1] 97 💬 |
5 |
5 asa, enemas, suppositories, corticosteroids |
- |
- |
- |
- |
097 [1] 97 💬 |
6 |
5-amino salicylic acid (5-asa) |
Mesalazine |
[2] D00097 D00097, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
7 |
5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
8 |
5-aminosalicylic acid(5-asa) and/or prednisone |
Aminosalicylic acid |
[3] D00162 D00162, D00377 D00377, D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
9 |
5-asa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [2] 96, 97 💬 |
10 |
5-asa (5-aminosalicylate) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
11 |
5-asa mmx |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
12 |
500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
13 |
750mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
14 |
81mg aspirin |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 [1] 49 💬 |
15 |
A novel synthetic, orally-administered, non-peptide small molecule, which acts as |
- |
- |
- |
- |
254 [1] 254 💬 |
16 |
Acetylsalicylic acid |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [4] 13, 46, 51, 210 💬 |
17 |
Acetylsalicylic acid at 1st visit, |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
18 |
Achim as solute (10^9 intestinal microbes/ml) |
- |
- |
- |
- |
051 [1] 51 💬 |
19 |
Acido ascorbico |
- |
- |
- |
- |
010 [1] 10 💬 |
20 |
Acido ascorbico dc.it |
- |
- |
- |
- |
010 [1] 10 💬 |
21 |
Acidum ascorbicum |
Ascorbic acid |
[1] D00018 D00018 💬 |
- |
- |
206 [1] 206 💬 |
22 |
Acidum ascorbicum d6 |
Ascorbic acid |
[1] D00018 D00018 💬 |
- |
- |
206 [1] 206 💬 |
23 |
Acr16 hydrochloride, asp2314 hydrochloride, fr310826 |
- |
- |
- |
- |
008 [1] 8 💬 |
24 |
Adeno-associated viral (aav) serotype 8 (aav2/8) vector with liver-specific thyroxine-binding globulin (tbg) promoter, driving the expression of the human arsb gene |
Levothyroxine |
[2] D01010 D01010, D08125 D08125 💬 |
THRA [2] THRA, THRB 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
019 [1] 19 💬 |
25 |
Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene |
- |
- |
- |
- |
113 [1] 113 💬 |
26 |
Adeno-associated viral vector serotype 9 containing the human n-acetyl-alpha-glucosaminidase gene |
- |
- |
- |
- |
019 [1] 19 💬 |
27 |
Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna |
Agalsidase alfa |
[1] D02784 D02784 💬 |
GLA [1] GLA 💬 |
Galactose metabolism [6] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism |
019 [1] 19 💬 |
28 |
Adeno-associated virus serotype 2/6 encoding human iduronate 2-sulfatase (hids) gene donor vector, sb-a6p-hnt donor vector |
Idursulfase |
[1] D04499 D04499 💬 |
IDS [1] IDS 💬 |
Glycosaminoglycan degradation [3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 [1] 19 💬 |
29 |
Adeno-associated virus serotype 2/6 encoding human iduronidase (hidua) gene donor vector, sb-a6p-hrl donor vector |
- |
- |
- |
- |
019 [1] 19 💬 |
30 |
Adeno-associated virus serotype 2/6 encoding left side-zinc finger nuclease (zfn1), sb-a6p-zleft vector |
- |
- |
- |
- |
019 [1] 19 💬 |
31 |
Adeno-associated virus serotype 2/6 encoding right side-zinc finger nuclease (zfn2), sb-a6p-zright vector |
- |
- |
- |
- |
019 [1] 19 💬 |
32 |
Adeno-associated virus-cftr vector |
- |
- |
- |
- |
299 [1] 299 💬 |
33 |
Allo-asc |
- |
- |
- |
- |
096 [1] 96 💬 |
34 |
Allo-asc-cd |
- |
- |
- |
- |
096 [1] 96 💬 |
35 |
Allo-asc-dfu |
- |
- |
- |
- |
036 [1] 36 💬 |
36 |
Aln-as1 |
- |
- |
- |
- |
254 [1] 254 💬 |
37 |
Amoxapine |
Amoxapine |
[1] D00228 D00228 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
046 [1] 46 💬 |
38 |
Amoxapine & dipyridamole |
Amoxapine |
[2] D00228 D00228, D00302 D00302 💬 |
PDE4A [4] PDE4A, PDE5A, SLC6A2, SLC6A4 💬 |
Metabolic pathways [8] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
39 |
As |
- |
- |
- |
- |
046 [6] 46, 53, 96, 97, 215, 271 💬 |
40 |
As inn |
- |
- |
- |
- |
097 [1] 97 💬 |
41 |
As2 |
- |
- |
- |
- |
006 [1] 6 💬 |
42 |
Asa |
- |
- |
- |
- |
013 [4] 13, 96, 97, 251 💬 |
43 |
Asacol |
- |
- |
- |
- |
097 [1] 97 💬 |
44 |
Asacol (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
45 |
Asacol (mesalamine) delayed-release tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
46 |
Asacol 400 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
47 |
Asacol 400 mg (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
48 |
Asacol 400 mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
49 |
Asacol 400mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
50 |
Asacol 800 mg (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
51 |
Asacol 800 mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
52 |
Asacol 800mg tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
53 |
Asacol delayed release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
54 |
Asacol delayed-release tablets |
- |
- |
- |
- |
097 [1] 97 💬 |
55 |
Asacol tablet |
- |
- |
- |
- |
097 [1] 97 💬 |
56 |
Asacol® |
- |
- |
- |
- |
097 [1] 97 💬 |
57 |
Asacol® 400 mg |
- |
- |
- |
- |
097 [1] 97 💬 |
58 |
Asasantin retard |
- |
- |
- |
- |
051 [1] 51 💬 |
59 |
Asasantin retard ® |
- |
- |
- |
- |
051 [1] 51 💬 |
60 |
Asb-683699 |
- |
- |
- |
- |
013 [1] 13 💬 |
61 |
Asc |
- |
- |
- |
- |
036 [4] 36, 51, 96, 97 💬 |
62 |
Ascal(r) / carbasalate calcium |
Calcium |
[1] D03385 D03385 💬 |
- |
- |
046 [1] 46 💬 |
63 |
Ascorbic acid |
Ascorbic acid |
[1] D00018 D00018 💬 |
- |
- |
010 [4] 10, 97, 206, 298 💬 |
64 |
Ascorbic acid (vitamin c) |
Ascorbic acid |
[1] D00018 D00018 💬 |
- |
- |
010 [1] 10 💬 |
65 |
Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e) |
Ascorbic acid |
[3] D00018 D00018, D02331 D02331, D02332 D02332 💬 |
- |
- |
206 [1] 206 💬 |
66 |
Ascorbic acid vit c |
Ascorbic acid |
[1] D00018 D00018 💬 |
- |
- |
010 [1] 10 💬 |
67 |
Ascs |
- |
- |
- |
- |
053 [2] 53, 96 💬 |
68 |
Ascs: adipose derived stem cells |
- |
- |
- |
- |
096 [1] 96 💬 |
69 |
Asendis |
- |
- |
- |
- |
046 [1] 46 💬 |
70 |
Asendis 50 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
71 |
Asf-1096 cream 0.25% |
- |
- |
- |
- |
049 [1] 49 💬 |
72 |
Asf-1096 cream 0.5% |
- |
- |
- |
- |
049 [1] 49 💬 |
73 |
Asf-1096 cream 1.0% |
- |
- |
- |
- |
049 [1] 49 💬 |
74 |
Asfotas alfa |
- |
- |
- |
- |
172 [1] 172 💬 |
75 |
Asfotase alfa |
Asfotase alfa |
[1] D10595 D10595 💬 |
ALPL [1] ALPL 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 [1] 172 💬 |
76 |
Asfotase alfa (alxn1215) |
Asfotase alfa |
[1] D10595 D10595 💬 |
ALPL [1] ALPL 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Thiamine metabolism |
172 [1] 172 💬 |
77 |
Ask nr. 21972 |
- |
- |
- |
- |
005 [1] 5 💬 |
78 |
Ask8007 |
- |
- |
- |
- |
046 [1] 46 💬 |
79 |
Asp015k |
- |
- |
- |
- |
046 [2] 46, 97 💬 |
80 |
Asp015k hydrobromide |
- |
- |
- |
- |
046 [1] 46 💬 |
81 |
Asp015k hydrobromide, as1940150-br, jkt-201a, 4-{[(1r,2s,3s,5s,7s)-5-hydroxy-2-adamantyl]amino}-1h-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide |
- |
- |
- |
- |
046 [1] 46 💬 |
82 |
Asp0367 |
- |
- |
- |
- |
113 [1] 113 💬 |
83 |
Asp1707 |
- |
- |
- |
- |
046 [1] 46 💬 |
84 |
Asp2408 |
- |
- |
- |
- |
046 [1] 46 💬 |
85 |
Asp2409 |
- |
- |
- |
- |
046 [1] 46 💬 |
86 |
Asp3291 |
- |
- |
- |
- |
097 [1] 97 💬 |
87 |
Asp3652 |
- |
- |
- |
- |
226 [1] 226 💬 |
88 |
Asp5094 |
- |
- |
- |
- |
046 [1] 46 💬 |
89 |
Asp6294 |
- |
- |
- |
- |
226 [1] 226 💬 |
90 |
Aspergillus oryzae |
Aspergillus oryzae |
- |
- |
- |
097 [1] 97 💬 |
91 |
Aspirin |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [11] 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
92 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
93 |
Aspirin 81mg tablet |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
94 |
Aspirin and meloxicam |
Acetylsalicylic acid |
[2] D00109 D00109, D00969 D00969 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
049 [1] 49 💬 |
95 |
Aspirin tablets |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
96 |
Assigned pulmonary hypertension medication |
- |
- |
- |
- |
086 [1] 86 💬 |
97 |
Ast-120 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
98 |
Astrorx |
- |
- |
- |
- |
002 [1] 2 💬 |
99 |
Asyn mab |
- |
- |
- |
- |
006 [1] 6 💬 |
100 |
Autologous asc |
- |
- |
- |
- |
051 [1] 51 💬 |
101 |
Avxs-101 (previously known as scaav9.cb.smn) |
- |
- |
- |
- |
003 [1] 3 💬 |
102 |
Azathioprine or mesalazine |
Azathioprine |
[3] D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
103 |
B2-asmedic |
- |
- |
- |
- |
097 [1] 97 💬 |
104 |
Behavioral: assessment of cognition |
- |
- |
- |
- |
006 [1] 6 💬 |
105 |
Behavioral: assessment of depression |
- |
- |
- |
- |
006 [1] 6 💬 |
106 |
Behavioral: assessment of disability |
- |
- |
- |
- |
013 [1] 13 💬 |
107 |
Behavioral: assessment of impact of ms on cognition |
- |
- |
- |
- |
013 [1] 13 💬 |
108 |
Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors |
- |
- |
- |
- |
006 [1] 6 💬 |
109 |
Behavioral: assessment of quality of life |
- |
- |
- |
- |
006 [1] 6 💬 |
110 |
Behavioral: assessment of severity of icd (impulse control disorders) |
- |
- |
- |
- |
006 [1] 6 💬 |
111 |
Behavioral: assessment of severity of parkinson disease |
- |
- |
- |
- |
006 [1] 6 💬 |
112 |
Behavioral: emotion assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
113 |
Behavioral: montreal cognitive assessment (moca) |
- |
- |
- |
- |
017 [1] 17 💬 |
114 |
Behavioral: neuro-psychological assessment |
- |
- |
- |
- |
240 [1] 240 💬 |
115 |
Behavioral: participant self-assessment surveys |
- |
- |
- |
- |
006 [1] 6 💬 |
116 |
Behavioral: physical exam and updrs part iii assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
117 |
Behavioral: quality of life assessment |
- |
- |
- |
- |
081 [1] 81 💬 |
118 |
Behavioral: smoking and alcohol assumption |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
298 [1] 298 💬 |
119 |
Bgj398 (also known as bbp-831) |
- |
- |
- |
- |
276 [1] 276 💬 |
120 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [1] 97 💬 |
121 |
Biological assays |
- |
- |
- |
- |
019 [1] 19 💬 |
122 |
Blood draw for the laboratory assessment |
- |
- |
- |
- |
303 [1] 303 💬 |
123 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
[14] D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
124 |
Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf |
Busulfan |
[8] D00107 D00107, D00142 D00142, D00248 D00248, D01907 D01907, D02115 D02115, D03235 D03235, D07966 D07966, D08556 D08556 💬 |
CSF3R [9] CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease [46] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 [1] 60 💬 |
125 |
Care as usual |
- |
- |
- |
- |
015 [1] 15 💬 |
126 |
Cbd - oral solution, is known as epidiolex, and is the approved name in the usa. |
- |
- |
- |
- |
140 [3] 140, 144, 158 💬 |
127 |
Cbd - oral solution, is known as epidyolex, and is the approved name |
- |
- |
- |
- |
156 [1] 156 💬 |
128 |
Cbd oral solution, is known as epidyolex and is the approved name in the eu |
- |
- |
- |
- |
156 [1] 156 💬 |
129 |
Cbd-oral solution, is known as epidiolex, and is the approved name in the usa. |
- |
- |
- |
- |
158 [1] 158 💬 |
130 |
Cere-120 (adeno-associated virus serotype 2 [aav2]-neurturin [ntn]) |
- |
- |
- |
- |
006 [1] 6 💬 |
131 |
Cere-120: adeno-associated virus delivery of neurturin |
- |
- |
- |
- |
006 [1] 6 💬 |
132 |
Clarithromycin (not used as of 4/2020) |
Clarithromycin |
[1] D00276 D00276 💬 |
- |
- |
006 [1] 6 💬 |
133 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d) trp-ly di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
134 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d)trp-ly di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
135 |
Cyclo((diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
136 |
D-aspartate |
- |
- |
- |
- |
013 [1] 13 💬 |
137 |
Delayed and extended release mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
138 |
Device: as domelock system |
- |
- |
- |
- |
046 [1] 46 💬 |
139 |
Device: measurment with aspirational medical device |
- |
- |
- |
- |
051 [1] 51 💬 |
140 |
Device: paired associative stimulation (pas) |
- |
- |
- |
- |
013 [1] 13 💬 |
141 |
Device: sleep assessment |
- |
- |
- |
- |
013 [1] 13 💬 |
142 |
Device: use of bioanalytical assay to monitor plasma levels of perhexiline |
Methamidophos |
[2] D05442 D05442, D08340 D08340 💬 |
CACNA1C [8] CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬 |
AMPK signaling pathway [45] AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
058 [1] 58 💬 |
143 |
Diagnostic test: audiology assessmentwith abr |
- |
- |
- |
- |
019 [1] 19 💬 |
144 |
Diagnostic test: auto-assessment manikins (sam) |
- |
- |
- |
- |
006 [1] 6 💬 |
145 |
Diagnostic test: frontal assessment battery (fab) |
- |
- |
- |
- |
006 [1] 6 💬 |
146 |
Diagnostic test: hearing assessment |
- |
- |
- |
- |
122 [1] 122 💬 |
147 |
Diagnostic test: neuropsychological assessment |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
148 |
Diagnostic test: scale for assessment and rating of ataxia |
- |
- |
- |
- |
113 [1] 113 💬 |
149 |
Diagnostic test: supplementary neuropsychological assessment - parkinson's disease |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
150 |
Diagnostic test: vestibular/balance assessment |
Isoxaflutole |
- |
- |
- |
122 [1] 122 💬 |
151 |
Dipyridamole and amoxapine |
Amoxapine |
[2] D00228 D00228, D00302 D00302 💬 |
PDE4A [4] PDE4A, PDE5A, SLC6A2, SLC6A4 💬 |
Metabolic pathways [8] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
152 |
Egcg as putative neuroprotective agent |
Epigallocatechin gallate |
- |
- |
- |
017 [1] 17 💬 |
153 |
Epinephrine |
Epinephrine |
[3] D00095 D00095, D00996 D00996, D02149 D02149 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [2] 46, 96 💬 |
154 |
Era as specific pah treatment |
- |
- |
- |
- |
086 [1] 86 💬 |
155 |
Extended release dipyridamole 200mg/aspirin 25mg |
Acetylsalicylic acid |
[2] D00109 D00109, D00302 D00302 💬 |
PDE4A [4] PDE4A, PDE5A, PTGS1, PTGS2 💬 |
Alzheimer disease [28] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 [1] 49 💬 |
156 |
Fludrocortisone |
Fludrocortisone |
[2] D00986 D00986, D07967 D07967 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
006 [3] 6 , 17, 81 💬 |
157 |
Gelatin |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
028 [4] 28, 78, 97, 269 💬 |
158 |
Genetic: optional pharmacogenetic assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
159 |
Genetic: recombinant adeno-associated virus acid alpha-glucosidase |
Alglucosidase alfa |
[1] D03207 D03207 💬 |
GAA [1] GAA 💬 |
Galactose metabolism [4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism |
256 [1] 256 💬 |
160 |
Givosiran (aln-as1) |
Givosiran |
[1] D11702 D11702 💬 |
ALAS1 [1] ALAS1 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism |
254 [1] 254 💬 |
161 |
Glutamate and aspartate |
- |
- |
- |
- |
013 [1] 13 💬 |
162 |
High dose aspirin (1300 mg/day) |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
163 |
Hm71224 multiple ascending dose |
- |
- |
- |
- |
046 [1] 46 💬 |
164 |
Hm71224 single ascending dose |
- |
- |
- |
- |
046 [1] 46 💬 |
165 |
Homeostasis model assessment of insulin resistance (homa) |
- |
- |
- |
- |
017 [1] 17 💬 |
166 |
Human albumin as macroaggregates |
Albumin human |
[2] D02792 D02792, D05424 D05424 💬 |
- |
- |
096 [1] 96 💬 |
167 |
Human coagulation factor viii associated with von willebrand factor (vwf) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
168 |
Imp will be labeled as ''pf-04236921 106mg/vial, clonal sc lyophilized form''. |
- |
- |
- |
- |
096 [1] 96 💬 |
169 |
Imp will be labeled as pf-04236921 106mg/vial, clonal sc lyophilized form |
- |
- |
- |
- |
096 [1] 96 💬 |
170 |
Insulin asparte |
- |
- |
- |
- |
299 [1] 299 💬 |
171 |
Interferon beta-1b and tacrolimus |
Human interferon beta |
[3] D00107 D00107, D00746 D00746, D08556 D08556 💬 |
IFNAR1 [7] IFNAR1, IFNAR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [47] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
172 |
Intraarticular morphine |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
173 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
174 |
Lcp-tacro (tacrolimus) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
095 [1] 95 💬 |
175 |
Low dose aspirin (162 mg/day) |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
176 |
Magnesium aspartate |
Magnesium |
[1] D02026 D02026 💬 |
- |
- |
298 [1] 298 💬 |
177 |
Magnesium aspartate hydrochloride |
Magnesium |
[1] D02026 D02026 💬 |
- |
- |
298 [1] 298 💬 |
178 |
Mesalamine, 5-aminosalicylic acid [5-asa] |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
179 |
Mesalamine, 5-asa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
180 |
Mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
046 [3] 46, 96, 97 💬 |
181 |
Mesalazine (3,600 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
182 |
Mesalazine (asacol®) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
183 |
Mesalazine (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
184 |
Mesalazine - tid 1000 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
185 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
186 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
187 |
Mesalazine 250mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
188 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
[2] D00377 D00377, D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
189 |
Mesalazine 4g enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
190 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
191 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
192 |
Mesalazine ec 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
193 |
Mesalazine enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
194 |
Mesalazine liquid enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
195 |
Mesalazine slow-release granules |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
196 |
Mesalazine sustained-release tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
197 |
Mesalazine tablet |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
198 |
Mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
199 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
[2] D00088 D00088, D00377 D00377 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
200 |
Mesalazine, tripterygium glycosides |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
201 |
Methotrexate as methotrexate disodium |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
202 |
Mmx mesalamine/ mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
203 |
Mmx mesalamine/mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
204 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
205 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
206 |
Mometasone |
Mometasone |
[3] D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [2] 98, 162 💬 |
207 |
Mometasone furoate |
Mometasone |
[3] D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
098 [2] 98, 162 💬 |
208 |
Morphine |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [5] 36, 46, 70, 85, 86 💬 |
209 |
Morphine hexal |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
210 |
Morphine hydrochloride |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
211 |
Morphine pca |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 [1] 70 💬 |
212 |
Morphine sulfate |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [3] 46, 85, 86 💬 |
213 |
Morphine sulphate in intrasite gel |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [1] 36 💬 |
214 |
Msc2430913a or ono-4641 (to be used as synonyms) |
- |
- |
- |
- |
013 [1] 13 💬 |
215 |
Neo-asa |
- |
- |
- |
- |
251 [1] 251 💬 |
216 |
Neoral soft gelatin capsules |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [2] 97, 269 💬 |
217 |
Non as of yet |
- |
- |
- |
- |
097 [1] 97 💬 |
218 |
None as of yet |
- |
- |
- |
- |
046 [1] 46 💬 |
219 |
None assigned |
- |
- |
- |
- |
231 [2] 231, 299 💬 |
220 |
Novorapid aspartate |
- |
- |
- |
- |
299 [1] 299 💬 |
221 |
Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone |
Mesalazine |
[7] D00377 D00377, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
222 |
Other: 5-asa withdrawal |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
223 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 [1] 98 💬 |
224 |
Other: eating assessment tool 10 |
- |
- |
- |
- |
002 [1] 2 💬 |
225 |
Other: eating assessment tool-10 |
- |
- |
- |
- |
002 [1] 2 💬 |
226 |
Other: mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
227 |
Other: monthly assessments of functional motor abilities by a trained therapist |
- |
- |
- |
- |
003 [1] 3 💬 |
228 |
Other: motor assessments before taking regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
229 |
Other: motor assessments on regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
230 |
Other: observation of ocrelizumab as treatment in rrms patients |
Ocrelizumab |
[1] D05218 D05218 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
013 [1] 13 💬 |
231 |
Other: oral glucose tolerance test (ogtt) assessment arm |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
232 |
Other: pentasa (mesalamine/ 5-aminosalicylic acid (5-asa) |
Aminosalicylic acid |
[2] D00162 D00162, D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
233 |
Other: quality of life assessment |
- |
- |
- |
- |
122 [1] 122 💬 |
234 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 [5] 34, 36, 51, 96, 298 💬 |
235 |
Other: rp% measurement by fcm as a diagnostic test for itp |
- |
- |
- |
- |
063 [1] 63 💬 |
236 |
Other: saline as a nasal spray |
- |
- |
- |
- |
226 [1] 226 💬 |
237 |
Other: ultrasonography assessment |
- |
- |
- |
- |
049 [1] 49 💬 |
238 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 [1] 51 💬 |
239 |
Overencapsulated mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
240 |
Polidocanol |
Polidocanol |
[1] D01993 D01993 💬 |
- |
- |
279 [1] 279 💬 |
241 |
Previously known as r935788 |
- |
- |
- |
- |
046 [1] 46 💬 |
242 |
Previously referred to as medi2070 and amg 139 |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
243 |
Previously referred to as medi2070 and amg 139, agn-151-598 |
- |
- |
- |
- |
096 [1] 96 💬 |
244 |
Procedure: assessment of therapy complications |
- |
- |
- |
- |
060 [1] 60 💬 |
245 |
Procedure: autologous hematopoietic stem cell transplantation (asct) |
- |
- |
- |
- |
028 [1] 28 💬 |
246 |
Procedure: bone marrow aspiration |
- |
- |
- |
- |
060 [2] 60, 285 💬 |
247 |
Procedure: ebus guided transbronchial needle aspiration (ebus-tbna) |
- |
- |
- |
- |
084 [1] 84 💬 |
248 |
Procedure: exhaled nitric oxide assessment |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
046 [1] 46 💬 |
249 |
Procedure: injections upper aspect of trigone of urinary bladder |
- |
- |
- |
- |
226 [1] 226 💬 |
250 |
Procedure: physical exam and updrs part iii assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
251 |
Procedure: pre liver transplantation laparoscopic hand assisted staging |
- |
- |
- |
- |
094 [1] 94 💬 |
252 |
Procedure: quality-of-life assessment |
- |
- |
- |
- |
028 [3] 28, 34, 51 💬 |
253 |
Procedure: quantiferon-tb gold assay |
Gold |
- |
- |
- |
046 [1] 46 💬 |
254 |
Procedure: slit lamp assessment and intra-ocular pressure measurement |
- |
- |
- |
- |
019 [1] 19 💬 |
255 |
Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects. |
Bifenthrin |
- |
- |
- |
046 [1] 46 💬 |
256 |
Qol assessment, neuropsychological |
- |
- |
- |
- |
034 [1] 34 💬 |
257 |
Recombinant adeno-associated viral vector expressing the human alpha-1-antitrypsin gene |
Alpha-1-proteinase inhibitor |
- |
- |
- |
231 [1] 231 💬 |
258 |
Recombinant adeno-associated viral vector serotype 2.7m8 containing the chrimsonr-tdtomato gene |
- |
- |
- |
- |
090 [1] 90 💬 |
259 |
Recombinant adeno-associated viral vector, serotype 2 (raav2/2) containing the human wild-type mitochondrial nadh dehydrogenase 4 gene (nd4) |
NADH |
- |
- |
- |
302 [1] 302 💬 |
260 |
Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a |
- |
- |
- |
- |
019 [1] 19 💬 |
261 |
Recombinant human alpha-galactosidase abbreviated as r-h-alpha-gal |
- |
- |
- |
- |
019 [1] 19 💬 |
262 |
Recombinant human somatotropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 [2] 78, 236 💬 |
263 |
Rectal tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
097 [1] 97 💬 |
264 |
Response to anakinra associated with methotrexate |
Anakinra |
[3] D00142 D00142, D02115 D02115, D02934 D02934 💬 |
DHFR [4] DHFR, DHFR2, IL1R1, IL1R2 💬 |
Amoebiasis [20] Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
046 [1] 46 💬 |
265 |
Response to infliximab associated with methotrexate |
Infliximab |
[3] D00142 D00142, D02115 D02115, D02598 D02598 💬 |
DHFR [3] DHFR, DHFR2, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 [1] 46 💬 |
266 |
Ropinirole (as hydrochloride) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
267 |
Safinamide (as add-on therapy) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
268 |
Saizen® solution for injection (referred as saizen®) |
- |
- |
- |
- |
078 [1] 78 💬 |
269 |
Sildenafil (as citrate) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
270 |
Sildenafil singly or in association with bosentan |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
271 |
Sin asignar |
- |
- |
- |
- |
299 [1] 299 💬 |
272 |
Sirolimus (formerly known as rapamycin) |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
035 [1] 35 💬 |
273 |
Sodio ascorbato dc.it |
- |
- |
- |
- |
010 [1] 10 💬 |
274 |
Somatotropin |
Somatotropin |
[1] D02691 D02691 💬 |
GHR [1] GHR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
003 [3] 3 , 78, 236 💬 |
275 |
Sorafenib (as tosylate) |
Sorafenib |
[2] D06272 D06272, D08524 D08524 💬 |
BRAF [8] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 |
Acute myeloid leukemia [87] Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway |
034 [1] 34 💬 |
276 |
Spd476 (mesalazine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
277 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
278 |
Sulphsalazine, pentasa, asacol, colazide, depentum |
- |
- |
- |
- |
097 [1] 97 💬 |
279 |
Symptomatic treatment, steroids, immunosuppressive agents( azathioprine, tacrolimus, mycophenolate mofetil) |
Azathioprine |
[8] D00107 D00107, D00238 D00238, D00752 D00752, D03033 D03033, D05094 D05094, D05095 D05095, D05096 D05096, D08556 D08556 💬 |
IMPDH1 [7] IMPDH1, IMPDH2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [35] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
280 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
281 |
Tacrolimus (advagraf) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
282 |
Tacrolimus (prograf®) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
283 |
Tacrolimus (tacro) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
065 [1] 65 💬 |
284 |
Tacrolimus and mmf |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
285 |
Tacrolimus capsule |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
286 |
Tacrolimus capsule (low-dose) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
287 |
Tacrolimus capsules |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [2] 222, 299 💬 |
288 |
Tacrolimus combined with prednisone |
Prednisone |
[3] D00107 D00107, D00473 D00473, D08556 D08556 💬 |
NR3C1 [6] NR3C1, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
289 |
Tacrolimus prolonged-release hard capsules |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
290 |
Tacrolimus tablets |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
291 |
Tacrolimus with methotrexate |
Methotrexate |
[4] D00107 D00107, D00142 D00142, D02115 D02115, D08556 D08556 💬 |
DHFR [7] DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [37] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 [1] 46 💬 |
292 |
Tafamidis meglumine 20 mg soft gelatin capsules |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
293 |
Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image) |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
294 |
Tafamidis meglumine 20mg soft gelatin capsule (commerical image) |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
295 |
Terbutaline |
Terbutaline |
[2] D00688 D00688, D08570 D08570 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
118 [1] 118 💬 |
296 |
The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. |
- |
- |
- |
- |
096 [1] 96 💬 |
297 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta |
- |
- |
- |
- |
096 [1] 96 💬 |
298 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta. |
- |
- |
- |
- |
096 [1] 96 💬 |
299 |
Theophylline |
Theophylline |
[5] D00371 D00371, D01712 D01712, D02017 D02017, D06103 D06103, D06104 D06104 💬 |
ADORA1 [19] ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
Alcoholism [24] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
236 [2] 236, 299 💬 |
300 |
Theophylline er |
Theophylline |
[5] D00371 D00371, D01712 D01712, D02017 D02017, D06103 D06103, D06104 D06104 💬 |
ADORA1 [19] ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
Alcoholism [24] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
236 [1] 236 💬 |
301 |
Tildrakizumab |
Tildrakizumab |
[1] D10400 D10400 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
162 [2] 162, 271 💬 |
302 |
Tildrakizumab 100 mg (one 1-ml injection of 100 mg/ml |
Tildrakizumab |
[1] D10400 D10400 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 [1] 271 💬 |
303 |
Tildrakizumab 100 mg/ml |
Tildrakizumab |
[1] D10400 D10400 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 [1] 271 💬 |
304 |
Tildrakizumab 200 mg (two 1-ml injections of 100 mg/ml) |
Tildrakizumab |
[1] D10400 D10400 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
271 [1] 271 💬 |
305 |
Tildrakizumab prefilled syringe |
Tildrakizumab |
[1] D10400 D10400 💬 |
IL23A [1] IL23A 💬 |
C-type lectin receptor signaling pathway [9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
162 [1] 162 💬 |
306 |
Treatment as usual (tau) |
- |
- |
- |
- |
085 [1] 85 💬 |
307 |
Urinary levels of piiinp as a marker of changes in renal function |
- |
- |
- |
- |
299 [1] 299 💬 |
308 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
[5] D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A [14] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [1] 96 💬 |
309 |
Vr040/aspirair® inhaler |
- |
- |
- |
- |
006 [1] 6 💬 |